Cargando…

Effect of Hepatocellular Carcinoma on Mortality Among Individuals With Hepatitis B or Hepatitis C Infection in New York City, 2001–2012

BACKGROUND: Hepatocellular carcinoma (HCC) is a complication of chronic hepatitis B and C virus (HBV and HCV) infection. New York City (NYC) has a high prevalence of HBV and HCV, and infected persons likely face increased mortality from HCC and other causes. We describe the mortality profile of NYC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, Miranda S, Bocour, Angelica, Tran, Olivia C, Qiao, Baozhen, Schymura, Maria J, Laraque, Fabienne, Winters, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041961/ https://www.ncbi.nlm.nih.gov/pubmed/30019001 http://dx.doi.org/10.1093/ofid/ofy144

Ejemplares similares

2501. Trends in viral hepatitis and hepatocellular carcinoma in New York City, 2001–2018
por: Latham, Ned H, et al.
Publicado: (2023)

Outcomes of Hepatitis C Virus Treatment in the New York City Jail Population: Successes and Challenges Facing Scale up of Care
por: Chan, Justin, et al.
Publicado: (2020)

The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014–2017
por: Chan, Justin, et al.
Publicado: (2020)

Hepatitis C Seroprevalence Among Consecutive Labor and Delivery Admissions in Two New York City Hospitals
por: Kushner, Tatyana, et al.
Publicado: (2020)

Validation of a surveillance-based definition for hepatitis B treatment eligibility.
por: Guerra, Kevin, et al.
Publicado: (2019)

Human Immunodeficiency Virus Infection Newly Diagnosed at Autopsy in New York City, 2008–2012
por: Ramaswamy, Chitra, et al.
Publicado: (2015)

Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE
por: Teixeira, Paul A., et al.
Publicado: (2018)

Chagas Disease in the New York City Metropolitan Area
por: Zheng, Crystal, et al.
Publicado: (2020)

The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection( )
por: Miller-Archie, Sara A, et al.
Publicado: (2022)

Hepatitis C Testing and Linkage to Care Among Adults on Probation in a Large US City
por: Kamis, Kevin F, et al.
Publicado: (2021)

Surveillance and Preparedness for Ebola Virus Disease — New York City, 2014
por: Benowitz, Isaac, et al.
Publicado: (2014)

Laboratory Response to Anthrax Bioterrorism, New York City, 2001
por: Heller, Michael B., et al.
Publicado: (2002)

Comparison of Tocilizumab vs Baricitinib in Clinical Outcomes Among Hospitalized Patients With COVID-19: Experience From a Public Hospital System in New York City
por: Sunny, Subin, et al.
Publicado: (2023)

Candida auris Colonization After Discharge to a Community Setting: New York City, 2017–2019
por: Bergeron, Genevieve, et al.
Publicado: (2020)

Rifampin Mono-Resistant Tuberculosis in New York City, 2010–2021: A Retrospective Case Series
por: Lindsey, Joseph A, et al.
Publicado: (2023)

Using the National Death Index to Identify Duplicate Cancer Incident Cases in Florida and New York, 1996–2005
por: Wohler, Brad, et al.
Publicado: (2014)

Socioeconomic Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 Serological Testing and Positivity in New York City
por: Lieberman-Cribbin, Wil, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System
por: Vo, Christopher, et al.
Publicado: (2023)

Carbapenem-Resistant Klebsiella pneumoniae Infection in Three New York City Hospitals Trended Downwards From 2006 to 2014
por: Park, Sun O., et al.
Publicado: (2016)

Estimated Prevalence of Tuberculosis Infection Among a New York City Clinic Population Using Interferon-gamma Release Assays
por: Stennis, Natalie L., et al.
Publicado: (2014)

Reduction in Risk of Death Among Patients Admitted With COVID-19 Between the First and Second Epidemic Waves in New York City
por: Bowen, Anthony, et al.
Publicado: (2022)

Prisoners Treated for Hepatitis C with Protease Inhibitor, New York, USA, 2012
por: Moorjani, Harish, et al.
Publicado: (2015)

Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Universal Genotyping in Tuberculosis Control Program, New York City, 2001–2003
por: Clark, Carla M., et al.
Publicado: (2006)

Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001
por: Holtz, Timothy H., et al.
Publicado: (2003)

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C
por: Matsuura, Kentaro, et al.
Publicado: (2018)

Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City
por: Sigel, Keith, et al.
Publicado: (2020)

All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
por: Roelens, Maroussia, et al.
Publicado: (2020)

SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic
por: Lalani, Tahaniyat, et al.
Publicado: (2021)

Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021
por: Levin-Rector, Alison, et al.
Publicado: (2022)

Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum
por: Falade-Nwulia, Oluwaseun, et al.
Publicado: (2019)

Cancer Mortality among Asians and Pacific Islanders in New York City, 2001–2010
por: Huang, Vivian, et al.
Publicado: (2013)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV
por: Cachay, Edward R, et al.
Publicado: (2018)

Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
por: Liu, Chun Jen, et al.
Publicado: (2021)

Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

T-Cell Exhaustion in HIV-1/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C
por: Caraballo Cortés, Kamila, et al.
Publicado: (2023)

Improving Diagnosis of Hepatitis C Virus Infection Using Hepatitis C Core Antigen Testing in a Resource-Poor Setting
por: Kannan, Ayswarya, et al.
Publicado: (2021)

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
por: Marathe, Gayatri, et al.
Publicado: (2022)

Do Stay at Home Orders and Cloth Face Coverings Control COVID-19 in New York City? Results From a SIER Model Based on Real-world Data
por: Li, Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ffjrbdkv2rl6en88qpabnmh01d